Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder (Q78426368)
Jump to navigation
Jump to search
scientific article published on 01 November 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder |
scientific article published on 01 November 2002 |
Statements
Anti-CD20 chimeric monoclonal antibody (rituximab) for the treatment of recalcitrant, life-threatening pemphigus vulgaris with implications in the pathogenesis of the disorder (English)
pemphigus vulgaris
1 reference
Thomas G Salopek
Sarvesh Logsetty
Edward E Tredget
1 November 2002